Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients

被引：60

作者：

Cheng, Shih-Lung ^{[1
,2
]}

Lin, Ching-Hsiung ^{[3
,4
]}

Wang, Chin-Chou ^{[5
,6
,7
]}

Chan, Ming-Cheng ^{[8
]}

Hsu, Jeng-Yuan ^{[8
]}

Hang, Liang-Wen ^{[9
]}

Perng, Diahn-Warng ^{[10
]}

Yu, Chong-Jen ^{[11
]}

Wang, Hao-Chien ^{[11
]}

机构：

[1] Far Eastern Mem Hosp, Dept Internal Med, Taipei, Taiwan

[2] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Taoyuan, Taiwan

[3] Changhua Christian Hosp, Div Chest Med, Changhua, Taiwan

[4] Chang Jung Christian Univ, Coll Hlth Sci, Tainan, Taiwan

[5] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Pulm,Dept Internal Med,Kaohsiung Med Ctr, Kaohsiung, Taiwan

[6] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Crit Care,Dept Internal Med,Kaohsiung Med Ctr, Kaohsiung, Taiwan

[7] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi Campus, Taoyuan, Taiwan

[8] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan

[9] China Med Univ Hosp, Sleep Med Ctr, Dept Internal Med, Taichung, Taiwan

[10] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan

[11] Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan South Rd, Taipei 10048, Taiwan

来源：

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2019年 / 118卷 / 01期

关键词：

COPD; GOLD guideline; CAT; mMRC; DISEASE SEVERITY; GOLD; CLASSIFICATION; OUTCOMES;

D O I：

10.1016/j.jfma.2018.06.018

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Background: The 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) proposed a new severity assessment system for emphasizing clinical symptom evaluation by COPD Assessment Test (CAT) or modified Medical Research Council (mMRC) dyspnea scores. The aim of the study was to evaluate the effectiveness of two scoring systems in evaluating COPD patients. Methods: A population based cross-sectional study employing computer-assisted telephone interviewing system (CATI) for surveying the epidemiology of COPD in Taiwan. Among 6600 subjects recruited (age > 40), 404 subjects (6.1%) were diagnosed as COPD. The comorbidities, COPD-related symptoms, health care resources utilization were compared between CAT and mMRC. Results: There were significant differences in all co-morbidities, symptom severity in favor of CAT as compared to mMRC. When comparing health care resources utilization, CAT and mMRC have equal effectiveness in evaluating patients with regular medical treatment. There were significant differences in emergency room visit and hospitalization in favor of mMRC. However, CAT was more effective in evaluating patients with ICU admission (P = 0.005). Conclusion: Compared with CAT and mMRC, there are individual benefits in the evaluation of clinical symptoms, co-morbidities and medical resources utilization for ER, hospitalization and ICU admission in COPD patients. Copyright (C) 2018, Formosan Medical Association. Published by Elsevier Taiwan LLC.

引用

页码：429 / 435

页数：7

共 22 条

[1]

Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort [J].